BioArctic AB (BRCTF)
29.44
-7.48
(-20.27%)
USD |
OTCM |
Oct 08, 16:00
BioArctic Gross Profit Margin (Quarterly) : 91.24% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 91.24% |
| March 31, 2026 | 95.53% |
| December 31, 2025 | 91.82% |
| September 30, 2025 | 90.84% |
| June 30, 2025 | 94.77% |
| March 31, 2025 | 99.11% |
| December 31, 2024 | 88.30% |
| September 30, 2024 | 89.44% |
| June 30, 2024 | 90.35% |
| March 31, 2024 | 92.46% |
| December 31, 2023 | -464.0% |
| September 30, 2023 | 72.99% |
| June 30, 2023 | -3.14K% |
| March 31, 2023 | 83.86% |
| December 31, 2022 | -2.10K% |
| September 30, 2022 | 77.54% |
| June 30, 2022 | -732.0% |
| March 31, 2022 | -785.5% |
| December 31, 2021 | -489.7% |
| September 30, 2021 | -608.5% |
| Date | Value |
|---|---|
| June 30, 2021 | -285.2% |
| March 31, 2021 | -269.9% |
| December 31, 2020 | -207.2% |
| September 30, 2020 | -100.9% |
| June 30, 2020 | -260.2% |
| March 31, 2020 | 30.71% |
| December 31, 2019 | 5.02% |
| September 30, 2019 | -0.54% |
| June 30, 2019 | 81.39% |
| March 31, 2019 | 64.72% |
| December 31, 2018 | 93.34% |
| September 30, 2018 | 80.50% |
| June 30, 2018 | 62.04% |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 98.59% |
| December 31, 2016 | 99.75% |
| September 30, 2016 | |
| June 30, 2016 | 63.55% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Hansa Biopharma AB | 53.57% |
| Swedish Orphan Biovitrum AB | 61.17% |
| Diamyd Medical AB | -32.07K% |
| BONESUPPORT HOLDING AB | 90.81% |
| BioInvent International AB | 0.00% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 5.57% |
| Return on Assets | 4.36% |
| Return on Invested Capital | 5.42% |
| Profit Margin (Quarterly) | -4.51% |
| Operating Margin (Quarterly) | -1.01% |
| Return on Net Operating Assets | 93.05% |